| Primary Cutaneous T-Cell Non-Hodgkin Lymphoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 82show all (up to 200) |
|---|
| → investigated in trials for | Fludarabinesmall molecule 23 trials (3 active) · roll-up of the cancer and its descendants | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 17 trials (4 active) · roll-up of the cancer and its descendants | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 16 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mogamulizumabmonoclonal_antibody 15 trials (6 active) · roll-up of the cancer and its descendants | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brentuximab Vedotinadc 14 trials (5 active) · roll-up of the cancer and its descendants | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 11 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 10 trials (7 active) · roll-up of the cancer and its descendants | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall_molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall_molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rituximabmonoclonal antibody 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mechlorethaminesmall_molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall_molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alemtuzumabmonoclonal antibody 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |